Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
37.62
-0.04 (-0.11%)
At close: Apr 1, 2026, 4:00 PM EDT
37.62
0.00 (0.00%)
After-hours: Apr 1, 2026, 5:40 PM EDT

GRDN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
48.96-71.0337.7249.6628.33
Depreciation & Amortization
22.3419.7718.2316.5616.53
Stock-Based Compensation
13.85131.49-6.09-3.3813.03
Other Adjustments
8.737.145.354.42.08
Change in Receivables
-8.55-25.49-14.3-16.79-7.71
Changes in Inventories
-0.88-1.154.43-8.12-0.24
Changes in Accounts Payable
16.413.236.313.379.78
Changes in Accrued Expenses
0.62-2.973.01-1.15-1.28
Changes in Other Operating Activities
-1.2-13.0316.16-6.02-2.02
Operating Cash Flow
100.2657.9670.8248.5258.5
Operating Cash Flow Growth
72.97%-18.16%45.95%-17.05%11.19%
Capital Expenditures
-19.55-16.37-14.56-16.77-9.28
Payments for Business Acquisitions
-13.42-14.71-0.99-2-4.4
Other Investing Activities
0.740.672.10.870.54
Investing Cash Flow
-32.23-30.41-13.44-17.9-13.15
Short-Term Debt Issued
-189.3269.525311
Short-Term Debt Repaid
--198.3-264.5-249-11
Net Short-Term Debt Issued (Repaid)
--9540
Long-Term Debt Issued
-15---
Long-Term Debt Repaid
-0.5-38-4-3.75-3.05
Net Long-Term Debt Issued (Repaid)
-0.5-23-4-3.75-3.05
Issuance of Common Stock
29.04119.78---
Repurchase of Common Stock
-29.04----
Net Common Stock Issued (Repurchased)
0119.78---
Other Financing Activities
-6.57-111.43-58.23-45.28-33.74
Financing Cash Flow
-7.07-23.65-57.23-45.03-36.79
Net Cash Flow
60.963.910.15-14.418.56
Free Cash Flow
80.7141.5956.2631.7549.22
Free Cash Flow Growth
94.05%-26.08%77.20%-35.48%11.17%
FCF Margin
5.57%3.39%5.38%3.49%6.21%
Free Cash Flow Per Share
1.280.67---
Levered Free Cash Flow
66.45-142.5634.5833.5426.76
Unlevered Free Cash Flow
66.2-67.7574.5249.8643.64
Updated Mar 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q